key: cord-0981242-obm3jryo
authors: Miyauchi, Masaya; Imamura, Teruhiko
title: Clinical implication of COVID‐19 associated bradycardia
date: 2021-06-19
journal: Clin Cardiol
DOI: 10.1002/clc.23674
sha: 448f71d49644d54d8a93f7f9eda28cdf1ac0ff8c
doc_id: 981242
cord_uid: obm3jryo

nan

Their findings are of great interest because infection and high fever are, in general, associated with tachycardia. Several concerns have been raised.

To further clarify the mechanism of COVID-19 associated bradycardia, it is of great interest to investigate the type of bradycardia: sinus bradycardia, AV block, or atrial fibrillation. Noncardiac causes should be carefully excluded, including sedation, conduction-suppressive medications, and hypothyroidism.

The causality between bradycardia and mortality remains unclear. Email: teimamu@med.u-toyama.ac.jp ORCID Teruhiko Imamura https://orcid.org/0000-0002-7294-7637

A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis